Home Current Issue Archives ePub Ahead-of-Print Collections Podcasts/Videos CE For Authors Journal Info
Skip Navigation LinksHome > December 2012 - Volume 112 - Issue 12 > First Drug Approved for Treating Diabetic Macular Edema
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000423497.23146.d9
Drug Watch

First Drug Approved for Treating Diabetic Macular Edema

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* Ranibizumab injection (Lucentis) is the first drug approved for the treatment of diabetic macular edema. It reduces endothelial cell proliferation, vascular leakage, and new blood vessel formation. Clinical trials found that the drug, which is administered monthly in an intravitreal injection, improved vision.

* Common adverse effects include bleeding into the conjunctiva, eye pain, eye floaters, and increased intraocular pressure.

© 2012 Lippincott Williams & Wilkins, Inc.

Login